Extracorporeal membrane oxygenation is indispensable for critically severe COVID-19 patients. However, it would be inapplicable to patients with a rare blood type or blood transfusion refusal. In that case, severely conservative fluid management with the sacrifice of renal functions and hydrocortisone therapy should be considered for better oxygenation.
Keywords: AKI; ARDS; COVID‐19; ECMO; hydrocortisone; rhesus.
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.